A propensity-matched analysis looks at whether GLP-1 receptor agonist use tracks with cancer incidence and overall survival in bladder and renal cell carcinoma.
Recap by typeshit. Post by @urotoday on X.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
A podcast clip argues GLP-1 drugs need longer-term thinking than a quick cosmetic fix, and pushes viewers to comment for the full episode.
Researchers at an autoimmune community gathering discussed how GLP-1 drugs are shifting thinking about health beyond the scale. Details are thin.
Loading…